Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
 
 


Ergebnis der Suche nach: "000000000"
im Bestand: Gesamter Bestand

531 - 540 von 652
<< < > >>


Artikel 531 Role of Tissue Doppler Imaging for Detection of Diastolic Dysfunction in the Elderly
Enthalten in High blood pressure & cardiovascular prevention Bd. 18, 4.11.2012, Nr. 4, date:12.2011: 187-193
Online Ressource
Artikel 532 Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia
Enthalten in American journal of cardiovascular drugs Bd. 10, 17.8.2012, Nr. 1, date:2.2010: 11-28
Online Ressource
Artikel 533 Rotavirus Infections and Vaccines
Enthalten in Pediatric drugs Bd. 12, 31.8.2012, Nr. 4, date:8.2010: 235-256
Online Ressource
Artikel 534 Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
Enthalten in Clinical pharmacokinetics Bd. 49, 18.12.2012, Nr. 9, date:9.2010: 567-571
Online Ressource
Artikel 535 Ruxolitinib
Enthalten in Drugs Bd. 72, 25.12.2012, Nr. 16, date:12.2012: 2117-2127
Online Ressource
Artikel 536 RVX 208
Enthalten in Drugs in R & D Bd. 11, 27.11.2012, Nr. 2, date:6.2011: 207-213
Online Ressource
Artikel 537 Safety and Efficacy of Buprenorphine/Naloxone in Opioid-Dependent Patients
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 21-26
Online Ressource
Artikel 538 Safety and Efficacy of Topical Diclofenac Sodium Gel for Knee Osteoarthritis in Elderly and Younger Patients
Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 1, date:1.2011: 27-40
Online Ressource
Artikel 539 Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis
Enthalten in Clinical drug investigation Bd. 30, 28.8.2012, Nr. 6, date:6.2010: 351-364
Online Ressource
Artikel 540 Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons — The GRAAL Trial
Enthalten in Clinical drug investigation Bd. 32, 13.12.2012, Nr. 7, date:7.2012: 451-463
Online Ressource


531 - 540 von 652
<< < > >>


E-Mail-IconAdministration